On his first day in office, President Donald Trump signed an executive order directing the Bureau of Prisons (BOP) to cease funding medical procedures, treatments, or drugs intended to align an inmate's physical appearance with the opposite sex. This directive was one of 27 executive orders issued simultaneously, reflecting a policy position that served as a central pillar of the president's 2024 campaign platform.

The legal challenge now before the Supreme Court centers on whether this executive order and the subsequent BOP memoranda implementing it are lawful. The policy effectively bans gender-affirming care for federal inmates, regardless of medical necessity or existing clinical standards. While the administration maintains that the order is a legitimate exercise of executive authority over federal spending and prison management, critics argue that the policy imposes cruel and unusual punishment by denying medically necessary care to a vulnerable population. The Court's eventual ruling will determine whether the BOP can enforce this categorical ban or if it violates the constitutional rights of incarcerated individuals.